Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 2 of 2: GR metrics. - Dataset (ID:20365)

Filter results: >>>>
Cell line Drug name Experimental replicate Timepoint Curve type (GR values) Curve type (relative cell counts) Experiment name Number of concentrations Cell doublings (DMSO control) GR50 GRmax GR_AOC GEC50 GRinf Hill slope (GR values) R-squared sigmoid fit (GR values) P-value sigmoid fit (GR values) R-squared flat fit (GR values) IC50 Emax AUC EC50 Einf Hill slope (relative cell counts) R-squared sigmoid fit (relative cell counts) P-value sigmoid fit (relative cell counts) R-squared flat fit (relative cell counts)
Hs 578T Dactolisib 2
sigmoid
sigmoid
Hs578T dactolisib 2
8 2.509
0.0128
-0.0617
0.655
0.0126
0.00741
0.79
0.974
1.78e-05
NA
0.0105
0.15
0.405
0.00638
0.203
1.04
0.985
3.67e-06
NA
HCC70 BX-912 2 72
sigmoid
sigmoid
HCC70 BX-912 0 2 72
8 1.693
1.25
0.00257
0.0619
1.25
-0.00649
5.0
0.971
2.55e-05
NA
1.44
0.311
0.961
1.2
0.306
5.0
0.956
8.35e-05
NA
HCC38 Trametinib 2 72
sigmoid
sigmoid
HCC38 trametinib 0 2 72
8 2.133
0.219
0.267
0.389
0.222
-0.00324
0.424
0.987
2.39e-06
NA
0.391
0.377
0.644
0.127
0.183
0.404
0.988
1.91e-06
NA
BT-549 ZSTK474 1 72
sigmoid
sigmoid
BT549 ZSTK474 0 1 72
8 1.861
0.58
0.213
0.256
0.583
-0.00205
0.771
0.992
5.43e-07
NA
1.12
0.394
0.788
0.428
0.261
0.767
0.989
1.49e-06
NA
HCC38 Dactolisib 2 72
sigmoid
sigmoid
HCC38 dactolisib 0 2 72
8 2.120
0.0118
-0.0557
0.668
0.0118
-0.00134
0.785
0.98
7.61e-06
NA
0.0145
0.204
0.447
0.00701
0.245
0.927
0.988
1.88e-06
NA
HCC38 AZD8055 3 72
sigmoid
sigmoid
HCC38 AZD8055 0 3 72
8 1.417
0.0464
0.0327
0.53
0.0463
0.000983
1.04
0.997
4.27e-08
NA
0.157
0.392
0.658
0.041
0.372
1.02
0.996
5.78e-08
NA
BT-549 Dactolisib 3 72
sigmoid
sigmoid
BT549 dactolisib 0 3 72
8 1.801
0.0058
-0.00929
0.751
0.00579
0.000747
0.866
0.994
2.41e-07
NA
0.011
0.282
0.442
0.00425
0.29
0.909
0.995
1.54e-07
NA